Abeona Therapeutics
ABEO
ABEO
48 hedge funds and large institutions have $128M invested in Abeona Therapeutics in 2024 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
20.78% more ownership
Funds ownership: 52.81% → 73.59% (+21%)
14% less funds holding
Funds holding: 56 → 48 (-8)
37% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 19
Holders
48
Holding in Top 10
3
Calls
$3.69M
Puts
$209K
Top Buyers
| 1 | +$15.6M | |
| 2 | +$7.81M | |
| 3 | +$7.42M | |
| 4 |
PBM
Propel Bio Management
Los Angeles,
California
|
+$5.29M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$4.92M |
Top Sellers
| 1 | -$1.24M | |
| 2 | -$935K | |
| 3 | -$535K | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$509K |
| 5 |
HF
HRT Financial
New York
|
-$500K |